BlackRock
ZIVO

BlackRock’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

BlackRock’s Portfolio ZIVO Stock Details ZIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-837
Closed -$12.2K – 5558
2023
Q2 		$12.2K Sell
837
-1,766
-68% -$30.1K ﹤0.01% 5240
2023
Q1 		$48.1K Buy
2,603
+85
+3% +$1.58K ﹤0.01% 5127
2022
Q4 		$37.8K Buy
2,518
+218
+9% +$3.81K ﹤0.01% 5279
2022
Q3 		$39K Sell
2,300
-527
-19% -$11.6K ﹤0.01% 5403
2022
Q2 		$66K Buy
+2,827
New +$56.9K ﹤0.01% 5357

Other funds holding ZIVO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return
BC
Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return

BlackRock's ZIVO Position: Q3 2023 in Review

BlackRock sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q3 2023, closing a stake of 837 shares — an estimated $12.2K sold.

BlackRock first reported a position in ZIVO in Q2 2022 and held it in 5 quarters. The position peaked at $66K in Q2 2022. 12 funds tracked by Wall St. Rank hold ZIVO as of Q3 2023.

  • BlackRock reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • BlackRock sold 837 Zivo Bioscience, Inc. Common Stock shares in Q3 2023, an estimated $12.2K.
  • BlackRock first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • BlackRock's Zivo Bioscience, Inc. Common Stock position peaked at $66K in Q2 2022.
  • 12 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q3 2023.

Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.